IMTAC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

13 results for “IMTAC”

Trials

Integrated Molecular Analysis of Cancer (IMAC)

1,800 participants · First posted Mar 5, 2014

Not yet recruiting

IMaC - Immune Pathways in Oesophagogastric Cancer

310 participants · First posted Sep 28, 2023

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

593 participants · First posted Sep 14, 2020

Drugs

iPS-CAR-iMac

CAR-iMAC Cell Therapy (cancer)

Organizations

IMAC Holdings

United States

News

BridGene and Takeda Form $770M Alliance to Tackle Undruggable Targets in Neurology and Immunology

BridGene Biosciences Secures $28 Million Series B+ Funding to Advance TEAD Inhibitor BGC-515 Toward Phase 2

Ignite Proteomics' RPPA Assay Drives Complete Response in HER2-Negative Breast Cancer

Page 1 of 2